TORRENT PHARMACEUTICALS LIMITED Torrent Pharmaceuticals Limited Share Price NSE India S.E.
Equities
TORNTPHARM
INE685A01028
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,817 INR | +1.29% |
|
-0.62% | +22.01% |
| 06-21 | Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India | RE |
| 06-06 | Torrent Pharma Signs Deal with Japan's Takeda to Market Acid-Related Disorders Drug in India | MT |
| Sales 2025 * | 121B 1.45B 115B | Sales 2026 * | 137B 1.64B 129B | Capitalization | 941B 11.27B 891B |
|---|---|---|---|---|---|
| Net income 2025 * | 20.43B 245M 19.36B | Net income 2026 * | 26.11B 313M 24.74B | EV / Sales 2025 * | 7.96 x |
| Net Debt 2025 * | 21.53B 258M 20.4B | Net Debt 2026 * | 8.42B 101M 7.98B | EV / Sales 2026 * | 6.95 x |
| P/E ratio 2025 * |
46.1
x | P/E ratio 2026 * |
36
x | Employees | 13,247 |
| Yield 2025 * |
0.9% | Yield 2026 * |
1.04% | Free-Float | 28.65% |
More Fundamentals
* Assessed data
More news
Latest transcript on Torrent Pharmaceuticals Limited
More recommendations
More press releases
| 1 day | +1.14% | ||
| 1 week | -0.62% | ||
| Current month | +0.78% | ||
| 1 month | +5.04% | ||
| 3 months | +5.41% | ||
| 6 months | +21.13% | ||
| Current year | +22.01% |
1 week
2 755.90
2 843.20
1 month
2 570.452 980.00
Current year
2 291.602 980.00
1 year
1 772.052 980.00
3 years
1 242.082 980.00
5 years
726.002 980.00
10 years
329.752 980.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sudhir Menon
DFI | Director of Finance/CFO | - | - |
| Compliance Officer | - | 31/07/22 | |
Jinesh Shah
COO | Chief Operating Officer | 47 | 31/07/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 22/06/82 | |
| Chairman | 60 | 31/12/85 | |
Nayantara Bali
BRD | Director/Board Member | 57 | 06/03/19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/24 | 2,817 | +1.29% | 285 602 |
| 01/07/24 | 2,781 | -0.36% | 376,124 |
| 28/06/24 | 2,791 | +0.71% | 130,761 |
| 27/06/24 | 2,772 | -0.68% | 229,004 |
| 26/06/24 | 2,791 | -1.41% | 184,605 |
Delayed Quote NSE India S.E., July 02, 2024 at 07:47 am
More quotes
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
Sector
Pharmaceuticals
Calendar
22/07/2024
- Q1 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
2,779
INR
Average target price
2,876
INR
Spread / Average Target
+3.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +56.86% | 823B | |
| +43.90% | 641B | |
| -6.57% | 352B | |
| +17.32% | 324B | |
| +9.94% | 301B | |
| +16.08% | 241B | |
| +2.29% | 223B | |
| +13.96% | 218B | |
| +7.98% | 167B |
- Stock Market
- Equities
- TORNTPHARM Stock
- TORNTPHARM Stock
